Knopman DS - Search Results

1

Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT. Knopman DS, et al. Nat Rev Dis Primers. 2021 May 13;7(1):33. doi: 10.1038/s41572-021-00269-y. Nat Rev Dis Primers. 2021. PMID: 33986301 Free PMC article. Review.

2

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Mohs RC, et al. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S13-21. Alzheimer Dis Assoc Disord. 1997. PMID: 9236948

3

Part VI. Primary drug therapies for Alzheimer's disease.

Knopman DS. Knopman DS. Dis Mon. 2000 Nov;46(11):745-60. doi: 10.1016/s0011-5029(00)90007-5. Dis Mon. 2000. PMID: 11130325 Review. No abstract available.

4

Pharmacotheraphy for Alzheimer's disease.

Knopman D. Knopman D. Curr Neurol Neurosci Rep. 2001 Sep;1(5):428-34. doi: 10.1007/s11910-001-0102-y. Curr Neurol Neurosci Rep. 2001. PMID: 11898553 Review.

5

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Jack CR Jr. Kantarci K, et al. Among authors: knopman ds. J Int Neuropsychol Soc. 2002 Nov;8(7):934-42. doi: 10.1017/s1355617702870084. J Int Neuropsychol Soc. 2002. PMID: 12405545 Free PMC article.

6

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC. Jack CR Jr, et al. Neurology. 2003 Jan 28;60(2):253-60. doi: 10.1212/01.wnl.0000042480.86872.03. Neurology. 2003. PMID: 12552040 Free PMC article. Clinical Trial.

7

Mild cognitive impairment in the oldest old.

Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, Ivnik R, Kokmen E, Tangalos E, Edland S, Knopman D, Petersen R. Boeve B, et al. Neurology. 2003 Feb 11;60(3):477-80. doi: 10.1212/wnl.60.3.477. Neurology. 2003. PMID: 12578930

8

Pharmacotherapy for Alzheimer's disease: 2002.

Knopman D. Knopman D. Clin Neuropharmacol. 2003 Mar-Apr;26(2):93-101. doi: 10.1097/00002826-200303000-00009. Clin Neuropharmacol. 2003. PMID: 12671529 Review.

9

Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.

Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr. Kantarci K, et al. Among authors: knopman ds. AJNR Am J Neuroradiol. 2003 May;24(5):843-9. AJNR Am J Neuroradiol. 2003. PMID: 12748083 Free PMC article.

10

Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Boeve BF, et al. Among authors: knopman ds. Neurology. 2003 Jul 8;61(1):40-5. doi: 10.1212/01.wnl.0000073619.94467.b0. Neurology. 2003. PMID: 12847154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,046 results

Search Page

Filters